Pelvic Floor Electric Stimulator Market Size Is Expected To Reach USD 427.15 Million By 2028

 San Francisco, 18 May 2021: The Report Pelvic Floor Electric Stimulator Market Size, Share & Trends Analysis Report By Application (Urinary Incontinence, Neurodegenerative Diseases, Sexual Dysfunction), By Region, And Segment Forecasts, 2021 - 2028

The global pelvic floor electric stimulator market size is anticipated to reach USD 427.15 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 11.5% from 2021 to 2028. Increasing prevalence of urinary incontinence, rising investment in research and development by key players, and growing awareness initiatives are some of the major factors anticipated to boost the market growth.

The increasing prevalence of chronic diseases and Urinary Incontinence (UI) are primary factors that are expected to drive the market growth. According to the NHS, around 61% of the male population is suffering from lower Urinary Tract Infections (UTI) and around 34% of women are living with some type of UI. This disorder costs around USD 301.40 million per year to the NHS, thereby, contributing to the market growth.

Moreover, the geriatric population is at a higher risk for developing various neurological conditions such as stroke, prostate cancer, and Alzheimer’s disease which may affect the lower urinary tract. This factor is anticipated to be one of the high growth rendering drivers of this market. As per the World Health Organization (WHO), the global population of 65 years and above is expected to rise from 7.00% in 2000 to 16.00% in 2050. This is expected to drive market growth.

Furthermore, the launch of technologically advanced products with comparatively lower prices is expected to drive market growth. For instance, in February 2020, Atlantic Therapeutics received the U.S. Food and Drug Administration (FDA), clearance for over-the-counter device INNOVO- wearable and non-invasive pelvic floor muscle stimulator for treating stress urinary incontinence.

Access Research Report of Pelvic Floor Electric Stimulator Market @ https://www.grandviewresearch.com/industry-analysis/pelvic-floor-electric-stimulator-market

Pelvic Floor Electric Stimulator Market Report Highlights

• Based on the application, the urinary incontinence segment dominated the market in 2020 with a revenue share of 84.87% owing to the increasing number of patients suffering from urinary incontinence globally
• North America dominated the market with the highest revenue share of 39.29% in 2020 owing to the rising incidence of targeted diseases, such as bladder obstruction, urinary incontinence, and Benign Prostatic Hyperplasia (BPH). Moreover, this region is one of the most advanced regions globally with innovative technologies and infrastructure, resulting in significant healthcare facilities and patient care
• However, Asia Pacific is expected to significantly lead the market from 2021 to 2028. The rising risk of UTIs in women with increasing age, vaginal deliveries, and surgeries is driving the regional market growth
• Some of the key players operating in this market are Zynex Inc.; TensCare Ltd.; Verity Medical Ltd.; InControl Medical; The Prometheus Group; Laborie, Inc.; ActivLife Technologies; Athena Feminine Technologies; Atlantic Therapeutics; and Renovia Inc.

List of Key Players in the Pelvic Floor Electric Stimulator Market

• Zynex Inc.
• TensCare Ltd.
• Verity Medical Ltd.
• InControl Medical
• The Prometheus Group
• Laborie, Inc.
• ActivLife Technologies
• Athena Feminine Technologies
• Atlantic Therapeutics
• Renovia Inc.

Access Press Release of Pelvic Floor Electric Stimulator Market @ https://www.grandviewresearch.com/press-release/global-pelvic-floor-electric-stimulator-market